Zurcher Kantonalbank (Zurich Cantonalbank) Xenon Pharmaceuticals Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 16,408 shares of XENE stock, worth $638,271. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,408

Previous 16,408 -0.0%

Holding current value

$638,271

Previous $645,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$36.12 - $43.96 $288 - $351	-8 Reduced 0.05%	16,408 $645,000
Q2 2024 Jul 29, 2024	SELL	$36.25 - $43.75 $538,820 - $650,300	-14,864 Reduced 47.52%	16,416 $640,000
Q1 2024 Apr 25, 2024	BUY	$42.66 - $50.04 $669,591 - $785,427	15,696 Added 100.72%	31,280 $1.35 Million
Q4 2023 Jan 30, 2024	BUY	$28.7 - $46.46 $113,680 - $184,028	3,961 Added 34.08%	15,584 $717,000
Q3 2023 Oct 25, 2023	BUY	$34.16 - $39.73 $83,008 - $96,543	2,430 Added 26.43%	11,623 $397,000
Q2 2023 Aug 07, 2023	SELL	$34.84 - $43.54 $3,971 - $4,963	-114 Reduced 1.22%	9,193 $353,000
Q1 2023 May 08, 2023	SELL	$33.46 - $40.35 $4,416 - $5,326	-132 Reduced 1.4%	9,307 $333,000
Q4 2022 Feb 01, 2023	BUY	$33.06 - $39.43 $91,642 - $109,299	2,772 Added 41.58%	9,439 $372,000
Q2 2022 Aug 09, 2022	SELL	$25.44 - $35.16 $1,679 - $2,320	-66 Reduced 0.98%	6,667 $203,000
Q1 2022 Apr 21, 2022	SELL	$25.09 - $33.13 $71,054 - $93,824	-2,832 Reduced 29.61%	6,733 $206,000
Q4 2021 Feb 01, 2022	BUY	$15.6 - $35.4 $83,678 - $189,885	5,364 Added 127.68%	9,565 $299,000
Q3 2021 Nov 15, 2021	BUY	$14.86 - $19.45 $1,634 - $2,139	110 Added 2.69%	4,201 $64,000
Q1 2021 May 03, 2021	BUY	$13.65 - $21.31 $55,842 - $87,179	4,091 New	4,091 $73,000

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Xenon Pharmaceuticals Inc. Transaction History